Recruiting

Transcutaneous Valve Therapy

Sponsor:

Hoag Memorial Hospital Presbyterian

Code:

NCT04167579

Conditions

Transcutaneous Valve Therapies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Transcutaneous Valve Therapy

Study Details

Brief summary:

The TVT Registry was designed to support a national surveillance system to assess the characteristics, treatments, and outcomes of patients receiving transcutaneous valve therapies.

Conditions

Transcutaneous Valve Therapies

Study ID

NCT04167579

Start date

May 20, 2019

Status verified date

Feb, 2023

Completion date

May 20, 2025

Anticipated

Primary completion date

May 20, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult patients (age 18 and older) who undergo an attempted transcutaneous aortic or mitral valve therapy procedure, with an FDA approved device.

Exclusion Criteria:

-

Study Design

Enrollment

5000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Transcutaneous Valve Therapy

Any patient who undergoes an attempted transcutaneous aortic or mitral valve therapy procedure, with an FDA approved device.

Primary outcome measure

  • Major adverse cardiac and cerebrovascular events [ Time Frame: 30 days from procedure ]

Central Contacts and Locations

Central contacts

Colleen Balius

9497641497colleen.balius@hoag.org

Locations

Hoah Memorial Hospital Presbyterian

Recruiting

Newport Beach, California, United States, 92663

Contacts

Colleen Balius, BSN, RN

949-764-1497colleen.balius@hoag.org

Principal Investigator:

Colleen Balius, BSN, RN

More Information

Sponsor

Hoag Memorial Hospital Presbyterian

Last update posted

Feb 28, 2023

Last verified

Feb, 2023

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Hoag Memorial Hospital Presbyterian on 2023-02-28.